Literature DB >> 28323720

Neuroprognostication after cardiac arrest in the light of targeted temperature management.

Mauro Oddo1, Hans Friberg.   

Abstract

PURPOSE OF REVIEW: Delayed awakening after targeted temperature management (TTM) and sedation is frequent among cardiac arrest patients. Differentiating between prolonged coma and irreversible cerebral damage can be challenging, therefore the utilization of a multimodal approach is recommended by international guidelines. Here, we discuss indications and advantages/disadvantages of available modalities for coma prognostication and describe new tools to improve our accuracy for outcome prediction. RECENT
FINDINGS: Studies from the TTM era confirmed that combining neurological examination with electrophysiological assessment [electroencephalography (EEG) and somato-sensory evoked potentials (SSEP)] greatly improves coma prognostication. This combination is nowadays recognized as the most useful by many clinicians and appears widely applicable as part of initial patient assessment. Additional tests (serum neuron specific enolase and neuroimaging) may be most useful to orient clinical decisions in patients with prolonged coma. Advanced analysis of EEG and SSEP recordings and the emergence of quantitative pupillometry hold great promise.
SUMMARY: Multimodal prognostication offers a comprehensive approach of anoxic-ischemic encephalopathy and is increasingly used in postresuscitation care. Worldwide implementation and future advancements of available modalities, together with the increasing use of novel automated devices for quantitative neurological examination, may further optimize prognostic accuracy in the early ICU phase following cardiac arrest.

Entities:  

Mesh:

Year:  2017        PMID: 28323720     DOI: 10.1097/MCC.0000000000000406

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

Review 1.  Neurological Prognostication After Cardiac Arrest in the Era of Target Temperature Management.

Authors:  Maximiliano A Hawkes; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 2.  Resuscitating the Globally Ischemic Brain: TTM and Beyond.

Authors:  Melika Hosseini; Robert H Wilson; Christian Crouzet; Arya Amirhekmat; Kevin S Wei; Yama Akbari
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

3.  Clinical observation of different targeted temperature management methods in patients with cardiac arrest.

Authors:  Hongjuan Huang; Yao Wang; Rong Wang; Jinxia Cai; Wei Wang; Xuan Zhang; Zhongman Zhang; Xufeng Chen; Jinsong Zhang; Gang Zhang; Yongxia Gao
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

4.  Neurologic Prognostication After Cardiac Arrest Using Brain Biomarkers: A Systematic Review and Meta-analysis.

Authors:  Ryan L Hoiland; Kiran J K Rikhraj; Sharanjit Thiara; Christopher Fordyce; Andreas H Kramer; Markus B Skrifvars; Cheryl L Wellington; Donald E Griesdale; Nicholas A Fergusson; Mypinder S Sekhon
Journal:  JAMA Neurol       Date:  2022-04-01       Impact factor: 29.907

5.  A prediction model for good neurological outcome in successfully resuscitated out-of-hospital cardiac arrest patients.

Authors:  Ward Eertmans; Thao Mai Phuong Tran; Cornelia Genbrugge; Laurens Peene; Dieter Mesotten; Jo Dens; Frank Jans; Cathy De Deyne
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-11-09       Impact factor: 2.953

Review 6.  SSEP retains its value as predictor of poor outcome following cardiac arrest in the era of therapeutic hypothermia.

Authors:  Ted L Rothstein
Journal:  Crit Care       Date:  2019-10-23       Impact factor: 9.097

7.  Derivation and validation of the CANP scoring model for predicting the neurological outcome in post-cardiac arrest patients.

Authors:  Gannan Wang; Zhongman Zhang; Xiaoquan Xu; Qingsong Sun; Haichen Yang; Jinsong Zhang
Journal:  Neurosciences (Riyadh)       Date:  2021-10       Impact factor: 0.735

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.